FDA approves first drug for spinal muscular atrophy - FDA Press Releases

The U.S. Food and Drug Administration today approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement. Spinraza is an injection administered into the fluid surrounding the spinal cord.

from Food and Drug Administration--Press Releases http://ift.tt/2hagXo6
via IFTTT